Literature DB >> 12653830

Primary immunodeficiency diseases: an update.

H Chapel1, R Geha, F Rosen.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12653830      PMCID: PMC1808666          DOI: 10.1046/j.1365-2249.2003.02110.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  1 in total

1.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

  1 in total
  30 in total

1.  Primary immune deficiencies--improving our understanding of their role in immunological disease.

Authors:  H M Chapel
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  The T cell response to persistent herpes virus infections in common variable immunodeficiency.

Authors:  M Raeiszadeh; J Kopycinski; S J Paston; T Diss; M Lowdell; G A D Hardy; A D Hislop; S Workman; A Dodi; V Emery; A D Webster
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 3.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

Review 4.  Traditional Chinese medicine and immune regulation.

Authors:  Hong-Di Ma; Yan-Ru Deng; Zhigang Tian; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

5.  Common variable immunodeficiency.

Authors:  Jonathan S Tam; John M Routes
Journal:  Am J Rhinol Allergy       Date:  2013 Jul-Aug       Impact factor: 2.467

Review 6.  Genetic evidence for the role of transforming growth factor-β in atopic phenotypes.

Authors:  Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Immunol       Date:  2019-06-01       Impact factor: 7.486

7.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

8.  [Adult-onset primary immunodeficiencies].

Authors:  S Gadola; U Salzer; H Schultz; B Grimbacher
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

9.  Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency.

Authors:  John B Hagan; Mary B Fasano; Sheldon Spector; Richard L Wasserman; Isaac Melamed; Mikhail A Rojavin; Othmar Zenker; Jordan S Orange
Journal:  J Clin Immunol       Date:  2010-05-08       Impact factor: 8.317

10.  Chronic bronchitis in immunocompromised patients: association with a novel Mycoplasma species.

Authors:  D Webster; H Windsor; C Ling; D Windsor; D Pitcher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.